NCT02413320View on ClinicalTrials.gov

Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2020

Conditions
Triple-negative Breast Cancer
Interventions
DRUG

Paclitaxel

DRUG

Carboplatin

DRUG

Doxorubicin

DRUG

Cyclophosphamide

DRUG

Docetaxel

Trial Locations (9)

64064

University of Kansas Cancer Center - Lee's Summit, Lee's Summit

64108

Truman Medical Center, Kansas City

64131

University of Kansas Cancer Center - South, Kansas City

64154

University of Kansas Cancer Center - North, Kansas City

66205

University of Kansas Cancer Center - CRC, Fairway

University of Kansas Cancer Center - Westwood, Westwood

66210

University of Kansas Cancer Center - Overland Park, Overland Park

67401

Salina Regional Health Center, Salina

67601

Hays Medical Center, Hays

Sponsors

Lead Sponsor

Priyanka Sharma
All Listed Sponsors
lead

Priyanka Sharma

OTHER

NCT02413320 - Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer | Biotech Hunter | Biotech Hunter